Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|October 18, 2014
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre studyUwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, et al.Melanoma Research|May 24, 2006
Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell linesKristina Büscher, Silvia Hahn, Maja Hofmann, et al.European Journal of Cancer (Oxford, England : 1990)|May 27, 2011
A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-upElisabeth Livingstone, Christine Windemuth-Kieselbach, Thomas K Eigentler, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 25, 2006
Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literatureSofiane Maza, Uwe Trefzer, Maja Hofmann, et al.Cancer|June 19, 2009
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanomaJeffrey S Weber, Hassan Zarour, Bruce Redman, et al.Melanoma Research|July 16, 2008
Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanomaAxel Hauschild, Uwe Trefzer, Claus Garbe, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2006
Multimodal fusion imaging ensemble for targeted sentinel lymph node management: initial results of an innovative promising approach for anatomically difficult lymphatic drainage in different tumour entitiesSofiane Maza, Mathias Taupitz, Kasra Taymoorian, et al.The Journal of Investigative Dermatology|March 11, 2006
Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosisLothar F Fecker, Christoph C Geilen, Georgi Tchernev, et al.Melanoma Research|November 10, 2007
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trialAlbrecht Reichle, Thomas Vogt, Brigitte Coras, et al.Pageof 7